Format

Send to

Choose Destination
Clin Calcium. 2012 Jun;22(6):897-903. doi: CliCa1206897903.

[Anti-osteoporosis drugs : their characteristics and evidence for anti-fracture efficacy].

[Article in Japanese]

Author information

1
Toranomon Hospital Endocrine Center, Japan.

Abstract

Remarkable progress in development of anti-fracture drugs has been achieved. Now we have anti-resorptive drugs, bisphosphonates and selective estrogen receptor modulators (SERMs) , bone anabolic one, teriparatide, and active vitamin D(3) analogues, alfacalcidol and eldecalcitol. Accumulating evidence shows their anti-fracture efficacy and safety profiles. We should learn fundamental evidence of those medicines as prescribing them to patients with osteoporosis.

PMID:
22653031
DOI:
CliCa1206897903
[Indexed for MEDLINE]

Supplemental Content

Loading ...
Support Center